Compile Data Set for Download or QSAR
Report error Found 277 Enz. Inhib. hit(s) with all data for entry = 4291
TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403946((2S,5R)-1-(2'-chloro-2-methoxy-[1,1'-biphenyl]-4-c...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403949((2S,5R)-5-(2-chlorophenyl)-1-(4-(2-methylthiophen-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403960((2S,5R)-5-(2-chlorophenyl)-1-(2',6'-dichloro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403941((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403945((2S,5R)-1-(2-chloro-[1,1'-biphenyl]-4-carbonyl)-5-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403937((2S,5R)-5-(2-chlorophenyl)-1-(2'-(trifluoromethyl)...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403938((2S,5R)-5-(2-chlorophenyl)-1-(2,2'-dimethoxy-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403939((2S,5R)-1-(4'-chloro-2'-methoxy-[1,1'-biphenyl]-4-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403931((2S,5R)-5-(2-chlorophenyl)-1-(2-methoxy-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403932((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-[1,1'-biphe...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403933((2S,5R)-5-(2-chlorophenyl)-1-(2',6'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403936((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-dichloro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403985((2S,5R)-5-(2-fluorophenyl)-1-(4-(2-methoxypyridin-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403987((2S,5R)-1-(4-(2,4-dimethoxypyrimidin-5-yl)benzoyl)...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403989((2S,35,5S)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403967((2S,5R)-5-(2-chlorophenyl)-1-(2'-(methoxymethyl)-[...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403968((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403961((2S,5R)-1-(2'-chloro-4'-methoxy-[1,1'-biphenyl]-4-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403964((2S,5R)-5-(2-fluorophenyl)-1-(2'-methoxy-[1,1'-bip...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404054((2S,5R)-1-(4-(2-chloro-4-methoxypyrimidin-5-yl)ben...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403997((2S,5R)-5-(3-fluorophenyl)-1-(2'-methoxy-[1,1'-bip...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM403991((2S,5R)-1-(4-(2,6-dimethoxypyridin-3-yl)benzoyl)-5...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404110((2S,5R)-5-(2-chlorophenyl)-1-(4-(6-methoxy-2-methy...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404101((2S,5R)-5-(2-chlorophenyl)-1-(2-fluoro-[1,1'-biphe...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404102((2S,5R)-5-(2-chlorophenyl)-1-(2'-fluoro-4'-methoxy...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404105((2S,5R)-5-(2-chlorophenyl)-1-(4'-fluoro-2'-methoxy...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404091((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-difluoro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404093((2S,5R)-5-(2-chlorophenyl)-1-(2-methyl-[1,1'-biphe...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404095((2S,5R)-5-(2,4-difluorophenyl)-1-(2'-methoxy-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404144((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,6-dimethylpyrid...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404137((2S,5R)-1-(2,2'-dimethoxy-[1,1'-biphenyl]-4-carbon...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404138((2S,5R)-1-(2-fluoro-2'-methoxy-[1,1'-biphenyl]-4-c...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404139((2S,5R)-5-(2-chlorophenyl)-1-(2-fluoro-2'-methoxy-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404133((2S,5R)-5-(2-chlorophenyl)-1-(3',5'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404134((2S,5R)-5-(2-chlorophenyl)-1-(2',5'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404122((2S,5R)-5-(2-chlorophenyl)-1-(2',3'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404124((2S,5R)-5-(2-chlorophenyl)-1-(3',4'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404170((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,4-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404156((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxy-4-(6-metho...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404152((2S,5R)-1-(3-chloro-4-(2,4-dimethoxypyrimidin-5-yl...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404184((2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-4'-(methy...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404185((2S,5R)-1-(4'-acetamido-2'-methoxy-[1,1'-biphenyl]...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404180((2S,5R)-5-(2-chlorophenyl)-1-(5'-cyano-2'-methyl-[...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404181((2S,5R)-5-(2-chlorophenyl)-1-(4-(4,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404182((2S,5R)-5-(2-chlorophenyl)-1-(4-(3,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404176((2S,5R)-1-(3'-amino-2'-methyl-[1,1'-biphenyl]-4-ca...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404177((2S,5R)-5-(2-chlorophenyl)-1-(2'-methyl-3'-(methyl...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404179((2S,5R)-5-(2-chlorophenyl)-1-(5'-cyano-2'-methoxy-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404171((2S,5R)-5-(2-bromophenyl)-1-(2'-methoxy-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandPNGBDBM404174((2S,5R)-5-(2-chlorophenyl)-1-(3'-cyano-2'-methoxy-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

Displayed 1 to 50 (of 277 total ) | Next | Last >>
Jump to: